vimarsana.com

Latest Breaking News On - Viral transport - Page 1 : vimarsana.com

FDA Outlines Transition For Medical Devices Distributed During Covid

Food Drug Administration FDA released final guidance documents to assist with the transition of medical devices that were legally distributed: subject to certain enforcement policies issued during the COVID-19 public health emergency PHE, Emergency Use Authorizations EUAs.

Virology Specimen Collection Market Research Report by Product Type, Sample, Region - Global Forecast to 2027

IISc-incubated startup Azooka Labs launches mWRAPR, India s first Indegenous Bio-sample Collection kit

Dr Pramod Kabra appointed as Chief Executive Officer of CPC Diagnostics, a subsidiary of Everlife Asia

Dr. Pramod Kabra appointed as Chief Executive Officer of CPC Diagnostics, a subsidiary of Everlife Asia 10/05/2021 02:00 PM CHENNAI, India, May 10, 2021 /PRNewswire/ CPC Diagnostics Pvt. Ltd. (“CPC”), a leading provider of In-Vitro Diagnostics (IVD) products and services in India, Sri Lanka, Nepal and Bangladesh and the Indian subsidiary of Everlife Asia (“Everlife”), has announced the appointment of Dr. Pramod Kabra as the company’s Chief Executive Officer. Based in Chennai, Dr. Kabra will be working closely with the Everlife team and local management to accelerate growth of the company by expanding reach and product offering, delivering superior performance to our partners and improving customer experience. He brings with him over 20 years of valuable and diverse industry experience notably in the Pharmaceutical, Diagnostic, and Clinical Research segments. Prior to joining CPC, he led the Specialty Diagnostics Group at Thermo Fisher Scientific. Throughout his career,

Diagnostic testing for Covid-19 checks active infection in patients, Microbiology Lab of GMC Srinagar conducts 1500 tests per day: Dr Anjum Farhana

Share Srinagar: Microbiology Department of Government Medical College, Srinagar runs a Covid-19 testing Lab which started functioning from March 14, 2020 and is conducting 1500 tests per day, Dr Anjum Farhana, HoD, Microbiology said the lab is a state of the art negative pressure lab BSL level (3) which was initially sanctioned and made functional in late 2017 as a molecular lab for influenza. Proper sampling along with good lab practices will give accuracy of results, she said while adding that these labs are designed to work on organisms causing serious disease via inhalation and prevent infection to health care workers. ‘Our lab is functional 24/7 and with capacity to do nearly 1500 tests per day. We have till date tested nearly 3 lakh samples’, Dr Anjum stated.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.